Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) EBIT Margin (2022 - 2025)

Cardio Diagnostics Holdings' EBIT Margin history spans 4 years, with the latest figure at 59950.86% for Q3 2025.

  • For Q3 2025, EBIT Margin fell 3853799.0% year-over-year to 59950.86%; the TTM value through Sep 2025 reached 41422.24%, down 1790881.0%, while the annual FY2024 figure was 23977.86%, 1846256.0% up from the prior year.
  • EBIT Margin for Q3 2025 was 59950.86% at Cardio Diagnostics Holdings, down from 22457.51% in the prior quarter.
  • Across five years, EBIT Margin topped out at 14398.71% in Q3 2023 and bottomed at 384998.84% in Q4 2022.
  • The 4-year median for EBIT Margin is 29039.51% (2023), against an average of 84521.76%.
  • The largest annual shift saw EBIT Margin skyrocketed 35595933bps in 2023 before it plummeted -14735856bps in 2025.
  • A 4-year view of EBIT Margin shows it stood at 384998.84% in 2022, then surged by 92bps to 29039.51% in 2023, then decreased by -16bps to 33608.2% in 2024, then plummeted by -78bps to 59950.86% in 2025.
  • Per Business Quant, the three most recent readings for CDIO's EBIT Margin are 59950.86% (Q3 2025), 22457.51% (Q2 2025), and 173463.83% (Q1 2025).